| COVID-19 |
0 |
0.3 |
| COVID-19 Vaccine |
0 |
0.3 |
| Guillain-Barre Syndrome |
0 |
1 |
| Influenza |
0 |
0.8 |
| Vaccines |
0 |
0.71 |
| Immunization |
0 |
0.64 |
| Influenza Vaccine |
0 |
0.56 |
| Biologic Therapy |
0 |
0.43 |
| Nerve |
0 |
0.36 |
| Adenovirus |
0 |
0.28 |
| Myelin |
0 |
0.28 |
| NHS |
0 |
0.23 |
| Intravenous Immunoglobulin (IVIG) |
0 |
0.21 |
| Brain |
0 |
0.2 |
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
0 |
0.2 |
| Immunoglobulin A (IgA) |
0 |
0.2 |
| Neuropathy |
0 |
0.2 |
| Middle Eastern Respiratory Syndrome (MERS) |
0 |
0.18 |
| Calcium |
0 |
0.16 |
| Demyelination |
0 |
0.12 |
| Weakness |
0 |
0.12 |
| Severe Acute Respiratory Syndrome |
0 |
0.11 |
| Arrhythmia |
0 |
0.09 |
| Osteoarthritis |
0 |
0.09 |
| Acute Respiratory Distress Syndrome |
0 |
0.08 |
| Cerebrospinal Fluid |
0 |
0.08 |
| Epidemic |
0 |
0.08 |
| Intravenous |
0 |
0.08 |
| Muscle |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Plasma |
0 |
0.08 |
| Swine Flu |
0 |
0.08 |
| UK Site Content |
0 |
0.08 |